Back to Dermatology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Plaque Psoriasis

Overview

Spherix’s coverage of the plaque psoriasis market focuses on the shift from long standing biologic treatments to alternative mechanisms of action, highlighting in-class competition.

Services Available

Trending market evolution

  • Plaque Psoriasis (US) - quarterly, n=100

  • Plaque Psoriasis (EU) - semiannual, n=250

Exploring the patient journey

  • Biologic/Small Molecule New Starts in PSO (US) - annual, n=1,000 patient charts

  • Biologic/Small Molecule Switching in PSO (US) - annual, n=1,000 patient charts

  • Biologic/Small Molecule Switching in PSO (EU) - annual, n=1,250 patient charts

Benchmarking new brand performance

  • Bimekizumab (UCB) in Psoriasis (US)*

*Pending approvals and launch

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Plaque Psoriasis Coverage